Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials

This publication has 62 references indexed in Scilit:

• Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen
  Melanoma Research, 2003
• Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
  The Journal of Experimental Medicine, 2002
• Is There a Standard for the Palliative Treatment of Melanoma?
  Oncology Research and Treatment, 2002
• Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients
  Melanoma Research, 2001
• Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon α2a and tamoxifen in metastatic melanoma
  Melanoma Research, 1999
• Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-?-2a in patients with metastatic melanoma
  Cancer, 1999
• Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial
  European Journal Of Cancer, 1998
• Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen
  European Journal Of Cancer, 1995
• Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A southwest oncology group study
  Medical and Pediatric Oncology, 1982
• Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma
  Cancer, 1977